Home/Filings/4/0001213900-25-073271
4//SEC Filing

ZENTMAN SAMUEL M 4

Accession 0001213900-25-073271

CIK 0001907223other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 6:00 AM ET

Size

7.3 KB

Accession

0001213900-25-073271

Insider Transaction Report

Form 4
Period: 2025-08-05
Transactions
  • Award

    Common Stock

    2025-08-05+153,494736,440 total
  • Award

    Non-Qualified Stock Option

    2025-08-07$0.41/sh+10,000$4,10040,000 total
    Exercise: $0.41Exp: 2035-01-16Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]The Reporting Person received the shares as contingent merger consideration.
  • [F2]The Reporting Person is the beneficial owner of the shares which are owned by The Samuel Zentman 2012 Irrevocable Trust.
  • [F3]Options are fully vested and can be exercised at any time.

Issuer

Klotho Neurosciences, Inc.

CIK 0001907223

Entity typeother

Related Parties

1
  • filerCIK 0001309349

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 6:00 AM ET
Size
7.3 KB